FIELD: clinical immunology.
SUBSTANCE: invention relates to medicine, in particular to clinical immunology, and is intended for the diagnosis of secondary immunodeficiency in military personnel participating in military conflicts. In the blood of a soldier the relative number of regulatory T-lymphocytes CD3+CD4+Foxp3+ is determined. Additionally, the expression of Toll-like receptors on TLR4 monocytes is determined. When the conditions CD3+CD4+Foxp3+≥0,9 and TLR4≤16 are met simultaneously, secondary immunodeficiency is diagnosed.
EFFECT: invention provides a simplification of the method, research time reduction and an expansion of the functionality of a method for diagnosing secondary immunodeficiency.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR FORECASTING SECONDARY IMMUNODEFICIENCY FORMATION | 2020 |
|
RU2747658C1 |
| DIAGNOSTIC TECHNIQUE FOR EXUDATIVE OTITIS MEDIA | 2019 |
|
RU2693049C1 |
| DIAGNOSTIC TECHNIQUE FOR SECONDARY IMMUNODEFICIENT DISEASE IN PULMONARY TUBERCULOSIS | 2012 |
|
RU2504784C1 |
| METHOD FOR DETERMINING IMMUNODEFICIENCY STATES BASED ON DETERMINING INTRACELLULAR VITAMINS | 2020 |
|
RU2734029C1 |
| DIAGNOSTIC TECHNIQUE FOR CELL DYSIMMUNITY IN CHEMICAL WORKERS EXPOSED TO FORMALDEHYDE | 2014 |
|
RU2539391C1 |
| METHOD OF DIAGNOSING EARLY MANIFEST CONGENITAL SYPHILIS | 2009 |
|
RU2402775C1 |
| METHOD FOR PREDISPOSITION DETERMINATION TO DEVELOPMENT OF EXUDATIVE OTITIS MEDIA | 2019 |
|
RU2698910C1 |
| MONOCYTIC SELF-SPECIFIC CELLS, STIMULATING AUTOTOLERANCE, AND THEIR USE IN PHARMACEUTIAL PREPARATIONS | 2004 |
|
RU2346041C2 |
| METHOD OF PREDICTING THE DEVELOPMENT OF METASTASES IN PATIENTS WITH UNRESECTABLE TRIPLE-NEGATIVE BREAST CANCER | 2023 |
|
RU2802141C1 |
| METHOD FOR PREDICTION OF THE RISK OF INFECTIOUS COMPLICATIONS IN ATOPIC DERMATITIS | 2018 |
|
RU2694223C1 |
